Regulatory Compliance

Delray Beach, Fla. – September 28, 2026 -- The global telehealth and telemedicine market is projected to grow from USD 118.8 billion in 2026 to USD 198.9 billion by 2031, expanding at a compound annual growth rate of 10.9%, according to a new report from MarketsandMarkets. A separate figure cited in the same report puts the 2025 market at USD 106.0 billion, underscoring the sector's rapid acceleration ahead of the forecast period.

New Orleans – September 28, 2026 -- Novogradac will convene community development entities, investors, developers and advisors at The Roosevelt New Orleans on Oct. 22-23 for its 2026 Fall New Markets Tax Credit Conference, focused on how NMTC financing is being deployed for housing-related development amid tightening market conditions.

Conference agenda targets compliance and allocation strategy

Sessions will cover the state of the NMTC program, an investor panel on market perspectives, an NMTC compliance overview, and how CDEs, investors and sponsors are positioning for current and future allocation cycles. Organizers say increased regulatory scrutiny is reshaping compliance expectations for program participants.

New Orleans – September 28, 2026 -- LabWare has launched LabWare WATER, a cloud-based SaaS platform designed to help smaller municipal water utilities manage sampling, laboratory testing, documentation, and regulatory reporting from a single system.

LabWare unveils WATER platform to cut compliance paperwork for utilities

The solution targets utilities that test in-house, outsource to contract laboratories, or run hybrid operations, replacing spreadsheets and paper records with a unified SaaS system. LabWare WATER covers the full compliance lifecycle, from scheduling monthly, quarterly, annual, and event-driven sampling to tracking chain-of-custody documentation and flagging exceedances, missing results, and overdue reporting deadlines.

Alexandria, Va. – September 28, 2026 -- ISC2, the nonprofit membership organization representing more than 270,000 certified cybersecurity professionals, has appointed Brionne Dawson as Executive Vice President for Advocacy, tasking her with elevating practitioner voices in policy debates over AI adoption, cyber resilience and workforce development.

Dawson joins ISC2 from Google after leading government affairs across 120-plus markets

Dawson brings more than two decades of experience in technology policy, government affairs and commercial diplomacy. She most recently led international government affairs for emerging markets across more than 120 countries at Google, later serving as Head of Middle East and Africa, where her portfolio covered AI policy, cybersecurity, cloud computing, digital trade and cross-border data flows.

McLean, Va. – September 28, 2026 -- ID.me, the digital identity wallet serving over 170 million users, has appointed Susannah Stroud Wright as Chief Legal Officer and Darragh Whelan as Executive Vice President of Engineering, expanding its executive team as the company scales AI-driven identity verification across federal and state agencies.

San Francisco – September 28, 2026 -- The Civil Infrastructure Platform (CIP), an open source project hosted by the Linux Foundation, has achieved compliance with IEC 62443-4-1 and IEC 62443-4-2, becoming one of the first open source initiatives to reach this level of industrial cybersecurity alignment.

CIP compliance cuts adopter security work by up to 70%

CIP estimates that manufacturers building on its security processes, technical capabilities and reusable artifacts can reduce their IEC 62443 compliance effort by up to 70%, while retaining responsibility for requirements specific to their own products and deployments.

North Chicago, Ill. – – September 28, 2026 -- AbbVie (NYSE: ABBV) has secured U.S. FDA approval for JUVMO (tavapadon), the first and only selective D1/D5 receptor agonist for adults with Parkinson's disease, with commercial availability set for October 2026.

JUVMO targets dopamine pathways differently than existing D2/D3 agonists

Roopal Thakkar, AbbVie's chief scientific officer, called the approval the first dopaminergic breakthrough for Parkinson's disease in decades. The once-daily oral tablet can be taken with or without levodopa, positioning it across the full disease continuum rather than a single treatment stage.

Tokyo – – September 28, 2026 -- TOYO Co., Ltd. (Nasdaq: TOYO; OTC: TOYWF) said it expects positive EBITDA for the second half of 2026 despite withholding specific revenue and net income guidance due to unresolved U.S. trade actions affecting its solar cell shipments.

Unresolved US Customs Probe Clouds Financial Visibility

The Tokyo-based solar manufacturer cited a pending U.S. Customs and Border Protection examination of its solar cell shipments as a key source of uncertainty for its second-half performance. TOYO said it will not issue quarterly guidance or specific financial metrics until greater regulatory clarity emerges.

Countervailing Duty Investigation Adds to Policy Risk

Active countervailing duty investigation proceedings compound the regulatory overhang facing the company, according to the statement. TOYO did not disclose a timeline for resolution of either the CBP examination or the CVD case.

Indianapolis – September 28, 2026 -- Eli Lilly and Company (NYSE: LLY) launched the Lilly Change the Course Commitment on Sept. 28, targeting treatment parity for diabetes and obesity patients between high-income countries and resource-limited settings by 2040. Today, for every four patients in high-income countries who access Lilly's diabetes and obesity medicines, only one patient in low- and middle-income countries (LMICs) can reach them.

Lilly targets registration of GLP-1 medicines across Africa, Latin America and Asia

The initiative rests on three pillars: adapting clinical development for resource-limited settings, accelerating registration of innovative medicines including GLP-1s in more LMICs, and strengthening primary health systems through training and digital tools. Lilly said it will prioritize regulatory filings and access pathways in Africa, Latin America and Asia, working with regulators, NGOs and global health organizations.

Delray Beach – September 28, 2026 -- The global hydrogen bus and truck market is projected to grow from $3.83 billion in 2026 to $8.95 billion by 2035, a 9.9% compound annual growth rate, according to MarketsandMarkets. Demand is concentrated in long-haul freight, high-utilization transit fleets and mining operations where battery-electric charging downtime remains commercially impractical.

India commits to 1,000 hydrogen commercial vehicles by 2030

India's National Green Hydrogen Mission is shifting from pilot programs to fleet-scale deployment, targeting more than 1,000 hydrogen trucks and buses in commercial use by 2030. The government plans refueling stations at roughly 200-kilometer intervals and is evaluating decentralized hydrogen production to improve fuel economics for medium and heavy commercial vehicles.